Ventricular Tachycardia Burden and Mortality: Association or Causality?

Michelle Samuel, Ihab Elsokkari, John L. Sapp

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

27 Citas (Scopus)

Resumen

Ventricular tachycardia (VT) is a potentially fatal cardiac rhythm disorder. Implantable cardioverter defibrillators (ICDs) are the primary management strategy for VT and have been shown to reduce the incidence of death but, ICDs do not reduce VT recurrences. Further, mounting evidence indicates that high VT burden, defined as the cumulative number of recurrent VTs or ICD shocks, is associated with an elevated risk of death; however, it is unclear if high VT burden is a cause of death or a marker of severe heart disease. Proposed mechanisms for a causal pathway suggest that multiple VT episodes or potential deleterious effects from ICDs might alter the myocardium of the ventricles to induce worsening heart disease, which might translate to an increased risk of mortality. In this review, we present the evidence to support association and causation hypotheses for the relationship between VT burden and risk of mortality and indicate potential gaps in evidence. Overall, there is insufficient evidence to prove causal hypotheses for the relationship between VT burden and mortality. Consistent definitions for VT burden, randomized controlled trials that assess the relationship between VT burden and mortality, and observational studies that capture VT burden are warranted to investigate if a potential causal relationship exists.

Idioma originalEnglish
Páginas (desde-hasta)454-464
Número de páginas11
PublicaciónCanadian Journal of Cardiology
Volumen38
N.º4
DOI
EstadoPublished - abr. 2022
Publicado de forma externa

Nota bibliográfica

Funding Information:
John L. Sapp reports research funding from Biosense Webster and Abbott , and speaker/consulting honoraria from Medtronic, Abbott , Varian and Biosense Webster, United States . The remaining authors have no conflicts of interest to disclose.

Funding Information:
There is increasing evidence that VT burden is positively associated with the risk of mortality, however, there is insufficient evidence to be confident that this is a causal relationship. Some evidence supports a causal role for ICD shocks in worsening clinical outcomes, but it remains unclear whether VT burden is a modifiable risk factor for death. Additional studies are required to further elucidate the difference in the potential causal mechanisms between ATP and shock burden and the risk of mortality. Consistent definitions for VT burden, RCTs that assess the relationship between VT burden and mortality, and observational studies that capture VT burden are warranted to investigate if a potential causal relationship exists.None. John L. Sapp reports research funding from Biosense Webster and Abbott, and speaker/consulting honoraria from Medtronic, Abbott, Varian and Biosense Webster, United States. The remaining authors have no conflicts of interest to disclose.

Publisher Copyright:
© 2022 The Authors

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine

PubMed: MeSH publication types

  • Journal Article
  • Review

Huella

Profundice en los temas de investigación de 'Ventricular Tachycardia Burden and Mortality: Association or Causality?'. En conjunto forman una huella única.

Citar esto